Common Contracts
15 similar Common Stock Purchase Warrant contracts by Mateon Therapeutics Inc, Digital Power Corp, DPW Holdings, Inc., Oncotelic Therapeutics, Inc.
ONCOTELIC THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • July 13th, 2023 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Oncotelic Therapeutics, Inc., a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below) as part of a unit purchased by the Holder from the Company pursuant to which the Holder is also purchasing from the Company notes convertible into shares of its Common Stock, $0.01 par value per share (the “Common Stock”) warrants to purchase 250,000 Common Stock (the “Offering”).
EDGEPOINT AI, INC. COMMON STOCK PURCHASE WARRANT ______________ (Date)Common Stock Purchase Warrant • March 26th, 2021 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) to purchase the common stock (the “EdgePoint Common Stock”) of EdgePoint AI, Inc. (“EdgePoint”), a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below). The Company is a wholly-owned subsidiary of Mateon Therapeutics, Inc. “Mateon”). This Warrant is issued to the Holder as part of a unit purchased by the Holder from Mateon pursuant to which the Holder is also purchasing notes from Mateon convertible into shares of Mateon common stock (the “Mateon Common Stock”) and shares of EdgePoint Common Stock, and warrants, including this Warrant, to purchase shares of Edgemont Common Stock (the “Company Warrants”) and warrants to purchase shares of Mateon Common Stock, (the “Offering”).
MATEON THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT __________________ (Date)Common Stock Purchase Warrant • March 26th, 2021 • Mateon Therapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Mateon Therapeutics, Inc., a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below) as part of a unit purchased by the Holder from the Company pursuant to which the Holder is also purchasing from the Company notes convertible into shares of its Common Stock, $0.01 par value per share (the “Common Stock”), shares of the common stock of EdgePoint AI, Inc. (“EdgePoint”), a subsidiary of the Company wholly-owned by it, warrants, including this Warrant, to purchase shares of Common Stock and warrants to purchase EdgePoint’s common stock, (the “Offering”).
MATEON THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT AUGUST 7, 2020Common Stock Purchase Warrant • August 13th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Mateon Therapeutics, Inc., a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below) as part of a unit purchased by the Holder from the Company pursuant to which the Holder is also purchasing from the Company notes convertible into shares of its Common Stock, $0.01 par value per share (the “Common Stock”), shares of the common stock of EdgePoint AI, Inc. (“EdgePoint”), a subsidiary of the Company wholly-owned by it, warrants, including this Warrant, to purchase shares of Common Stock and warrants to purchase EdgePoint’s common stock, (the “Offering”).
EDGEPOINT AI, INC. COMMON STOCK PURCHASE WARRANT AUGUST 7, 2020Common Stock Purchase Warrant • August 13th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) to purchase the common stock (the “EdgePoint Common Stock”) of EdgePoint AI, Inc. (“EdgePoint”), a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below). The Company is a wholly-owned subsidiary of Mateon Therapeutics, Inc. “Mateon”). This Warrant is issued to the Holder as part of a unit purchased by the Holder from Mateon pursuant to which the Holder is also purchasing notes from Mateon convertible into shares of Mateon common stock (the “Mateon Common Stock”) and shares of EdgePoint Common Stock, and warrants, including this Warrant, to purchase shares of Edgemont Common Stock (the “Company Warrants”) and warrants to purchase shares of Mateon Common Stock, (the “Offering”).
EDGEPOINT AI, INC. COMMON STOCK PURCHASE WARRANT JULY 23, 2020Common Stock Purchase Warrant • July 29th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) to purchase the common stock (the “EdgePoint Common Stock”) of EdgePoint AI, Inc. (“EdgePoint”), a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below). The Company is a wholly-owned subsidiary of Mateon Therapeutics, Inc. “Mateon”). This Warrant is issued to the Holder as part of a unit purchased by the Holder from Mateon pursuant to which the Holder is also purchasing notes from Mateon convertible into shares of Mateon common stock (the “Mateon Common Stock”) and shares of EdgePoint Common Stock, and warrants, including this Warrant, to purchase shares of Edgemont Common Stock (the “Company Warrants”) and warrants to purchase shares of Mateon Common Stock, (the “Offering”).
MATEON THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT JULY 23, 2020Common Stock Purchase Warrant • July 29th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Mateon Therapeutics, Inc., a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below) as part of a unit purchased by the Holder from the Company pursuant to which the Holder is also purchasing from the Company notes convertible into shares of its Common Stock, $0.01 par value per share (the “Common Stock”), shares of the common stock of EdgePoint AI, Inc. (“EdgePoint”), a subsidiary of the Company wholly-owned by it, warrants, including this Warrant, to purchase shares of Common Stock and warrants to purchase EdgePoint’s common stock, (the “Offering”).
MATEON THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT February 14, 2020Common Stock Purchase Warrant • June 29th, 2020 • Mateon Therapeutics Inc • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Mateon Therapeutics, Inc., a corporation duly organized and validly existing under the laws of Delaware (the “Company”), is issued to the Holder (as defined below) by the Company in accordance with the terms of the Warrant Purchase Agreement between the Company and the Holder dated as of February __, 2020 pursuant to which Warrant the Holder ha the right to purchase shares of the Company’s Common Stock, $0.01 par value per share (the “Common Stock”) as set forth herein.
DPW HOLDINGS, INC. COMMON STOCK PURCHASE WARRANT JULY 3, 2019Common Stock Purchase Warrant • September 20th, 2019 • DPW Holdings, Inc. • Electronic components, nec • Delaware
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of DPW Holdings, Inc., a Delaware corporation (the “Company”), is issued by the Company as of the date hereof pursuant to that certain Exchange Agreement dated of even date herewith, by and between the Company and the Holder (the “Exchange Agreement”). All terms used but not defined herein shall have the meanings ascribed thereto in the Exchange Agreement.
DPW HOLDINGS, INC. COMMON STOCK PURCHASE WARRANT JULY 3, 2019Common Stock Purchase Warrant • July 5th, 2019 • DPW Holdings, Inc. • Electronic components, nec • Delaware
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of DPW Holdings, Inc., a Delaware corporation (the “Company”), is issued by the Company as of the date hereof pursuant to that certain Exchange Agreement dated of even date herewith, by and between the Company and the Holder (the “Exchange Agreement”). All terms used but not defined herein shall have the meanings ascribed thereto in the Exchange Agreement.
DPW HOLDINGS, INC. COMMON STOCK PURCHASE WARRANT MARCH 23, 2018Common Stock Purchase Warrant • March 26th, 2018 • DPW Holdings, Inc. • Electronic components, nec • Delaware
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of DPW Holdings, Inc., a Delaware corporation (the “Company”), is issued to the Holder (as defined below) relating to a 12% Note of even date (the “Note”). This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 23, 2018, by and between the Company and the Holder (the “Purchase Agreement”).
DIGITAL POWER CORPORATION COMMON STOCK PURCHASE WARRANT AUGUST 3, 2017Common Stock Purchase Warrant • August 9th, 2017 • Digital Power Corp • Electronic components, nec • California
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Digital Power Corporation, a corporation duly organized and validly existing under the laws of California (the “Company”), is issued to the Holder (as defined below) in connection with a 12% Convertible Note (the “Note”). This Warrant is exercisable for up to an aggregate 666,666 shares of Common Stock, as defined below, subject to adjustment pursuant to the anti dilution provisions therein.
DIGITAL POWER CORPORATION REDEEMABLE COMMON STOCK PURCHASE WARRANT May __, 2017Common Stock Purchase Warrant • May 31st, 2017 • Digital Power Corp • Electronic components, nec • New York
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Digital Power Corporation, a corporation duly organized and validly existing under the laws of California (the “Company”), is issued to the Holder (as defined below) as part of a unit purchased by the Holder from the Company pursuant to which the Holder is also purchasing shares of the Company’s Series C Preferred Stock from the Company (the “Offering”)..
DIGITAL POWER CORPORATION REDEEMABLE COMMON STOCK PURCHASE WARRANT OCTOBER 21, 2016Common Stock Purchase Warrant • October 27th, 2016 • Digital Power Corp • Electronic components, nec • Nevada
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Digital Power Corporation, a corporation duly organized and validly existing under the laws of California (the “Company”), is issued to the Holder (as defined below) in connection with a 12% Secured Convertible Promissory Note (the “Note”) and another warrant (the “Warrant-CS1”) that the Holder is also simultaneously acquiring from the Company. This Warrant is exercisable for up to an aggregate 265,000 shares of Common Stock, as defined below, subject to adjustment pursuant to the anti dilution provisions therein.
DIGITAL POWER CORPORATION REDEEMABLE COMMON STOCK PURCHASE WARRANT OCTOBER 21, 2016Common Stock Purchase Warrant • October 27th, 2016 • Digital Power Corp • Electronic components, nec • Nevada
THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) of Digital Power Corporation, a corporation duly organized and validly existing under the laws of California (the “Company”), is issued to the Holder (as defined below) in connection with a 12% Secured Convertible Promissory Note (the “Note”) and another warrant (the “Warrant-CS2”) that the Holder is also simultaneously acquiring from the Company. This Warrant is exercisable for up to an aggregate 265,000 shares of Common Stock, as defined below, subject to adjustment pursuant to the anti dilution provisions therein.
